Tandem-base mutations occur in mouse liver and adipose tissue preferentially as G:C to T:A transversions and accumulate with age

Environmental and Molecular Mutagenesis

Volumn 33, Issue 4, 1999, Pages 320-324

  Buettner, Victoria L ^a   Hill, Kathleen A ^a   Halangoda, Asanga ^a   Sommer, Steve S ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Diet; Lacl transgene; Lipophilic mutagen; Mutagen; Spontaneous mutation

Indexed keywords

MUTAGENIC AGENT;

ADIPOSE TISSUE; AGE; ANIMAL TISSUE; ARTICLE; BREAST CANCER; FAT INTAKE; LIVER; MOUSE; MUTATION RATE; NONHUMAN; SPONTANEOUS MUTATION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION;

EID: 0032769369     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1999)33:4<320::AID-EM9>3.0.CO;2-S     Document Type: Article

References (28)

1. Beard WA, Osheroff WP, Prasad R, Sawaya MR, Jaju M, Wood TG, Kraut J, Kunkel TA, Wilson SH. 1996. Enzyme-DNA interactions re-quired for efficient nucleotide incorporation and discrimination in human DNA polymerase β. J Biol Chem 271:12141-12144.
2. Blaszyk H, Hartmann A, Liao D, Kovach JS, Sommer SS. 1996. Evidence for diverse mutagens in breast cancer. Lancet 348:683-684.
3. Bubley GJ, Ashburner BP, Teicher BA. 1991. Spectrum of cis-diamminedichloroplatinum(II)-induced mutations in a shuttle vector propagated in human cells. Mol Carcinog 4:397-406.
4. Buettner VL, Hill KA, Nishino H, Schaid DJ, Frisk CS, Sommer SS. 1996. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue transgenic mice. Oncogene 13:2407-2413.
5. Buettner VL, Nishino H, Haavik J, Knöll A, Hill KA, Sommer SS. 1997. Spontaneous mutation frequencies and spectra in p53 (+/+) and p53 (-/-) mice: a test of the "guardian of the genome" hypothesis in the Big Blue transgenic mouse mutation detection system. Mutat Res 379:13-20.
6. Chen H, Shaw BR. 1994. Bisulfite induces tandem double CC → TT mutations in double-stranded DNA. 2. Kinetics of cytosine deamination. Biochemistry 33:4121-4129.
7. Davies R, Oreffo VIC, Martin EA, Festing MFW, White INH, Smith LL, Styles JA. 1997. Tamoxifen causes gene mutations in the livers of lambda/lacI transgenic rats. Cancer Res 57:1288-1293.
8. de Boer JG, Erfle H, Walsh D, Holcroft J, Provost JS, Rogers B, Tindall KR, Glickman BW. 1997. Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice. Environ Mol Mutagen 30:273-286.
9. de Boer JG, Glickman BW. 1998. The lacI gene as a target for mutation in transgenic rodents and Escherichia coli. Genetics 148:1441-1451.
10. de Boer JG, Provost S, Gorelick N, Tindall K, Glickman BW. 1998. Spontaneous mutation in lacI transgenic mice: a comparison of tissues. Mutagenesis 13:109-114.
11. Farabaugh PJ. 1978. Sequence of the lacI gene. Nature 274:765-775.
12. Gorelick NJ. 1995. Overview of mutation assays in transgenic mice for routine testing. Environ Mol Mutagen 25:218-230.
13. Hartmann A, Blaszyk H, Kovach JS, Sommer SS. 1997. The molecular epidemiology of p53 gene mutations in human breast cancer. Trends Genet 13:27-33.
14. Hill KA, Buettner VL, Glickman BW, Sommer SS. 1999. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat Res Minirev 436:11-19.
15. Hutchinson F. 1994. Induction of tandem-base change mutations. Mutat Res 309:11-15.
16. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Putman DL, Sorge JA, Short JM. 1991. Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacI shuttle vector. Environ Mol Mutagen 18:316-321.
17. Leavitt SA, DeAngelo AB, George MH, Ross JA. 1997. Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver. Carcinogenesis 18:2101-2106.
18. Lung ML, Chan WC, Zong YS, Tang CM, Fok CL, Wong KT, Chan LK, Lau KW. 1996. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China. Cancer Epidemiol Biomarkers 5:277-284.
19. Matsuda T, Kawanishi M, Yagi T, Matsui S, Takebe H. 1998. Specific tandem GG to TT base substitutions induced by acetaldehyde are due to intra-strand crosslinks between adjacent guanine bases. Nucleic Acids Res 26:1769-1774.
20. Nishino H, Knöll A, Buettner VL, Frisk CS, Maruta Y, Haavik J, Sommer SS. 1995. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene 11:263-270.
21. Nishino H, Buettner VL, Haavik J, Schaid DJ, Sommer SS. 1996a. Spontaneous mutation in Big Blue transgenic mice: analysis of age, gender, and tissue type. Environ Mol Mutagen 28:299-312.
22. Nishino H, Buettner VL, Sommer SS. 1996b. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques. Mutat Res 372:97-105.
23. Prasad R, Beard WA, Wilson SH. 1994. Studies of gapped DNA substrate binding by mammalian DNA polymerase ß. J Biol Chem 269: 18096-18101.
24. Reid TM, Loeb LA. 1993. Tandem double CC→TT mutations are produced by reactive oxygen species. Proc Natl Acad Sci USA 90: 3904-3907.
25. Ross JA, Leavitt SA. 1998. Induction of mutations by 2-acetyl aminofluorene in lacI transgenic B6C3F1 mouse liver. Mutagenesis 13:173-179.
26. Sommer SS, Ketterling RP. 1996. The factor IX gene as a model for analysis of human germline mutations: an update. Hum Mol Genet 5:1505-1514.
27. Tao KS, Urlando C, Heddle JA. 1993. Comparison of somatic mutation in a transgenic versus host locus. Proc Natl Acad Sci USA 90:10681-10685,
28. Walker VE, Gorelick NJ, Andrews JL, Craft TR, DeBoer JG, Glickman BW, Skopek TR, 1996. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Cancer Res 56:4654-4661.